An anti-CD28 singe chain antibody prevents diabetes onset in NOD mice

被引：0
|
作者：
Nagelin, A [1 ]
Douhan, J [1 ]
Whitters, MJ [1 ]
Collins, M [1 ]
O'Hara, RM [1 ]
机构：
[1] Genet Inst, Cambridge, MA 02140 USA
来源：
FASEB JOURNAL | 2001年 / 15卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：A1211 / A1211
页数：1
相关论文
共 50 条
  • [31] ANTI-CD28 ANTIBODY IMPROVES SURVIVAL IN "MEMORY MICE'' WITH SEPSIS VIA IL-10 RELEASED BY REGULATORY T CELLS
    Sun, Yini
    Chen, Ching-wen
    Liang, Zhe
    Zhang, Wenxiao
    Coopersmith, Craig M.
    Ford, Mandy L.
    SHOCK, 2019, 51 (06): : 122 - 122
  • [32] Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
    Suntharalingam, Ganesh
    Perry, Meghan R.
    Ward, Stephen
    Brett, Stephen J.
    Castello-Cortes, Andrew
    Brunner, Michael D.
    Panoskaltsis, Nicki
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10) : 1018 - 1028
  • [33] T-LYMPHOCYTES FROM AGED MICE ARE LESS RESPONSIVE TO STIMULATION WITH ANTI-CD28
    ENGWERDA, C
    HANDWERGER, B
    FOX, B
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08) : A278 - A278
  • [34] REMISSION OF ESTABLISHED DIABETES IN DIABETIC NOD MICE USING ANTI-CD3 MONOCLONAL-ANTIBODY
    CHATENOUD, L
    THERVET, E
    PRIMO, J
    BACH, JF
    COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES, 1992, 315 (06): : 225 - 228
  • [35] An Anti-CD28 Domain Antibody, Lulizumab, in Systemic Lupus Erythematosus: Results of a Phase II Study
    Merrill, Joan T.
    Shevell, Diane E.
    Duchesne, Dominique
    Nowak, Miroslawa
    Kundu, Sudeep
    Girgis, Ihab G.
    Hu, Yanhua Sarah
    Nadler, Steven G.
    Banerjee, Subhashis
    Throup, John
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [36] A Novel Anti-CD28 Domain Antibody Antagonist Shows a Favorable Pharmacokinetic, Pharmacodynamic and Safety Profile
    Shi, R.
    Honczarenko, M.
    Zhang, S.
    Fleener, C. A.
    Mora, J.
    Lee, S.
    Liu, X.
    Shevell, D. E.
    Yang, Z.
    Wang, H.
    Murthy, B.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [37] Anti-CD28 Antagonism Using a Monovalent Fab Antibody for the Prolongation of Human Skin Allograft Survival
    Zaitsu, M.
    Issa, F.
    Hester, J.
    Milward, K.
    Vanhove, B.
    Wood, K.
    TRANSPLANTATION, 2014, 98 : 26 - 26
  • [38] Topological requirements and signaling properties of T cell-activating, anti-CD28 antibody superagonists
    Lühder, F
    Huang, Y
    Dennehy, KM
    Guntermann, C
    Müller, I
    Winkler, E
    Kerkau, T
    Ikemizu, S
    Davis, SJ
    Hanke, T
    Hünig, T
    JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (08) : 955 - 966
  • [39] Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects
    Shi, Rong
    Honczarenko, Marek
    Zhang, Sean
    Fleener, Catherine
    Mora, Johanna
    Lee, Sun Ku
    Wang, Reena
    Liu, Xiaoni
    Shevell, Diane E.
    Yang, Zheng
    Wang, Haiqing
    Murthy, Bindu
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (02) : 161 - 172
  • [40] PREVENTION OF DIABETES BUT NOT INSULITIS IN NOD MICE INJECTED WITH ANTIBODY TO CD4
    HAYWARD, AR
    SHRIBER, M
    COOKE, A
    WALDMANN, H
    JOURNAL OF AUTOIMMUNITY, 1993, 6 (03) : 301 - 310
12345